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Prevalence of influenza vaccination and its
association with health conditions and risk
factors among Kansas adults in 2013: a
cross-sectional study
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Abstract
Background: According to the Centers for Disease Control and Prevention, approximately 5-20 % of people are affected
by influenza annually, and influenza causes more than 200,000 hospitalizations each year. The purpose of this study is to
estimate the prevalence of influenza vaccination among high risk adults in Kansas.
Methods: The 2013 Kansas BRFSS data (n = 20,712) were analyzed to assess the prevalence of receiving influenza
vaccination among Kansas adults, overall and for selected demographic characteristics within the past 12 months.
Crude and adjusted prevalence rate ratios were computed using univariate logistic regression models with influenza
vaccination as the dependent variable and health conditions or high risk groups as the main independent variables;
these models were then adjusted for potential confounding.
Results: Overall, influenza vaccination rate was lower than the Healthy People 2020 target (42.2 % vs. 80 %). The
prevalence of receiving influenza vaccination was higher among adults 65 years and older compared to adults
64 years and younger after adjusting for gender, annual household income, education, marital status, insurance
status, and race/ethnicity. Similarly, the prevalence of receiving influenza vaccination was higher among adults
who have current asthma, or have ever been diagnosed with diabetes, high blood pressure, cancer (excluding skin),
and COPD compared to those who did not have these health conditions, as well as pregnant women compared to
women who were not pregnant.
Conclusions: Although high risk groups have higher rates of influenza vaccination compared to low risk groups, more
concerted efforts are needed to improve seasonal influenza vaccination in Kansas.
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Background
Seasonal influenza, commonly known as “the flu”, is a
contagious viral respiratory illness, which can cause
mild to severe illness. Unlike the common cold, influ-
enza can lead to hospitalization, life-threatening com-
plications and death [1]. According to the Centers for
Disease Control and Prevention (CDC), approximately
5-20 % of people living in the United States are affected
by influenza annually, and influenza causes more than
200,000 hospitalizations for influenza related illness
and complications each year [1, 2]. Deaths due to influ-
enza vary drastically year to year due to the unpredict-
ability, length and severity of the influenza season.
Thus, the range of influenza-related mortality over a
thirty-year period, between 1976 and 2007 in the
United States, is estimated at a low of approximately
3,000 to a high of approximately 49,000 deaths per year
[2]. It is difficult to have a more precise estimate of the
annual mortality associated with influenza for several
reasons including: influenza is not a reportable disease,
* Correspondence: bfaseru@kumc.edu
1Kansas Department of Health and Environment, Bureau of Health
Promotion, 1000 SW Jackson Suite 200, Topeka 66619, Kansas, USA
2Department of Preventive Medicine and Public Health, University of Kansas
Medical Center, 3901 Rainbow Boulevard, MS 1008, Kansas City, KS 66160,
USA
Full list of author information is available at the end of the article
© 2016 Santaularia et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Santaularia et al. BMC Public Health  (2016) 16:185 
DOI 10.1186/s12889-016-2884-5
influenza is infrequently listed on death certificates [1],
and the severity and duration of flu season varies from
year to year. Therefore, the influenza specific mortality
rates reported annually are only a tip of the iceberg.
The financial burden of influenza in the United States is
enormous. One study estimated that annual influenza epi-
demics result in an average of 610,660 potential life-years
lost, 3.1 million hospitalized days, and 31.4 million out-
patient visits based on the 2003 U.S. population [3]. The
direct medical cost is around $10.4 billion annually, and
the projected lost earnings due to influenza related illness
and loss of life sums to $16.3 billion annually. The esti-
mated total economic burden of annual influenza epi-
demics is approximately $87.1 billion [3].
Although adults with certain chronic health conditions
and adults in certain high-risk groups are not at increased
risk of contracting influenza, they can suffer more serious
medical consequences if they contract influenza [3]. For
example, adults with chronic health conditions such as
asthma are at increased risk of experiencing worsened
asthma symptoms when they contract influenza infec-
tion [3]. Influenza can also lead to pneumonia and
other acute respiratory diseases [4]. One study demon-
strated increased mortality of coronary heart disease as-
sociated with influenza epidemics [5]. In addition,
adults 65 years and older are victims of approximately
90 % of influenza associated deaths [1]. These conse-
quences for people who are at high risk for developing
flu-related complications indicate why it is imperative
that these adults avoid getting influenza.
Annual vaccination is the most effective way to prevent
influenza [6]. Healthy People 2020 set the target prevalence
rate for seasonal influenza vaccine for pregnant women
and non-institutionalized adults aged 18 to 64 years at
80 % [7]. The target prevalence rate for influenza vaccine
for non-institutionalized high-risk adults (adults with
chronic health conditions) aged 18 to 64 years and non-
institutionalized adults aged 65 years and older was set at
90 % [7]. However, influenza vaccination rates remain
below recommendations in the general adult population in
the United States. According to CDC, the seasonal influ-
enza vaccine rates for all groups at high-risk of developing
influenza-related complications are below the Healthy
People 2020 target objective. For the 2010–2011 influenza
season, the estimated national coverage was 40.5 % among
adults aged 18 years and older. The influenza vaccine
coverage was 69.6 % among adults aged 65 years and older
and 46.7 % among adults aged 18 to 64 years with at least
one selected high-risk chronic health conditions (such as
asthma) measured by the Behavioral Risk Factor Surveil-
lance System (BRFSS) [8]. Increasing influenza vaccine up-
take is one way to reduce hospitalization and healthcare
spending, particularly among the elderly with more than
one chronic disease [9].
Vaccines are a cost-effective, core component of any
preventive service [10]. Immunization programs utilize
surveillance systems to better understand vaccination
coverage and identify strategies to reach those at the
highest risk for influenza complication. It is critical to
monitor influenza vaccination rates among those who
are at high risk for developing influenza-related compli-
cations in order to avoid the onset of disease, reduce
mortality and health care cost since these are the people
who have the most serious consequences once infected
with influenza.
The purpose of this study is to estimate the prevalence
of influenza vaccination among specific high-risk groups
susceptible to influenza complications in Kansas in 2013.
Methods
Study design and protocol
The Kansas BRFSS is an ongoing, annual, population-
based cross-sectional random-digit-dial telephone survey
of non-institutionalized adults 18 years and older living
in a private residence with landline and/or cell phone
service (dual frame sampling) in Kansas. In 2013, the land-
line component of the dual frame sampling methodology
involved disproportionate stratified sampling which in-
cluded selection of landline telephone numbers within 10
geographic strata. In 2013, the cell phone component of
the dual frame sampling methodology comprised of
sampling from the entire state as a single stratum. The
samples (telephone numbers) that were drawn from each
geographic stratum was based on the population size
within each geographic stratum.
Study setting and participants
Kansas is a US Midwestern state. In 2013, the estimated
population of Kansas is approximately 2.8 million people
with approximately 2.6 million adults 18 years and older.
The 2013 Kansas BRFSS survey was administered daily
between January 2 and December 31, 2013 in English
and Spanish. The study was approved by the Department
of Health and Environment Institutional Review Board. A
total of 20,712 respondents 18 years and older completed
the survey.
Measures
All of the questions below were asked of all 20,712
respondents 18 years and older. Prevalence of the influ-
enza vaccination was determined by the question: "There
are two ways to get the influenza vaccine, one is a shot
in the arm and the other is a spray, mist, or drop in the
nose called FluMist™. During the past 12 months, have
you had either a seasonal flu shot or a seasonal flu vac-
cine that was sprayed in your nose?". Response options
were “yes,” “no,” “don’t know,” and “refused.” Adults
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who answered “yes” to this question were defined as
those who have received the seasonal influenza vaccine.
There were five dichotomous chronic health condi-
tions and five dichotomous high risk groups that were
assessed for their association with receipt of influenza
vaccination. We examined five health conditions prone
to influenza-related complications measured in BRFSS
as defined by CDC [11]. Adults were asked individually
for each health condition if they had ever been told by a
doctor, nurse, or healthcare professional that they had dia-
betes, high blood pressure, cancer (excluding skin cancer),
Chronic Obstructive Pulmonary Disease (COPD), and
asthma. Those who indicated that they had been diagnosed
with asthma were then asked if they currently had asthma.
The five high-risk groups prone to influenza-
related complications, as defined by CDC [11], measured
in BRFSS included: people 65 years and older, pregnant
women, American Indians, adults living in households
with children, and adults with a BMI greater than 40.
Adults living in households with children were defined
as those who provided a valid numerical response to the
question “How many children less than 18 years of age
live in your household.” Additionally, respondents’ body
weights were estimated by asking, “How much do you
weigh without shoes?” and height was measured by,
“About how tall are you without shoes?” BMI was then
calculated as weight in kilograms divided by height in
meters-squared (kg/m2). Morbidly obese weight was cat-
egorized as body mass index (BMI) equal to or greater
than 40 kg/m2 calculated using weight and height.
Statistical analysis
Weighted survey procedures were implemented using
SAS software version 9.3 and SAS callable SUDAAN
11.0.1 to account for the complex survey design of BRFSS.
A description of weighted survey procedures can be found
in the document - “Alternatives for Analysis of Complex
Sample Surveys: A Comparison of SAS®, SUDAAN®, and
AM® Software” available on-line [12]. Weighted data ana-
lysis is important since it also allows the generalization of
findings to the whole population, not just those who
responded to the survey. The options used in SUDDAAN
to do this include: NEST and WEIGHT. The prevalence
of receiving influenza vaccination among Kansas adults,
along with corresponding 95 % confidence intervals, were
calculated overall and for selected demographic character-
istics. Univariate logistic regression models were examined
with influenza vaccination as the dependent variable and
health conditions or high risk groups as the main inde-
pendent variables. Then, multivariable logistic regression
models were examined with influenza vaccination as the
dependent variable and health conditions or high risk
groups as the main independent variables with additional
covariates to adjust for potential confounding. Crude and
adjusted prevalence rate ratios (PRR) were computed to
examine the prevalence of influenza vaccination among
adults with each health condition or each high risk
group and significant relationships were determined by
95 % confidence intervals exclusive of 1 and the Rao-
Scott Chi-Square test p-value less than 0.05. The key
social demographic characteristics that were used to
adjust for confounding included age, race/ethnicity,
marital status, education, annual household income and
healthcare coverage.
Results
In 2013, the prevalence of receiving influenza vaccin-
ation within the past 12 months was 42.2 % (95 % CI:
41.4 - 43.0) among Kansas adults 18 years and older.
The prevalence of influenza vaccination by demographic
characteristics is shown in Table 1. Prevalence of influ-
enza vaccination status by health risk behaviors and
chronic health conditions is demonstrated in Table 2.
Table 3 shows the crude and adjusted prevalence rate
ratios of influenza vaccine coverage among Kansas
adults with chronic health conditions and in high-risk
groups compared to those who do not have the health
conditions or are not in the high-risk groups. The preva-
lence of receiving influenza vaccination within the past
12 months were significantly higher among adults who
have current asthma, or have ever been diagnosed with
diabetes, high blood pressure, cancer (excluding skin),
and COPD compared to those who did not have these
health conditions. The prevalence of receiving influenza
vaccination within the past 12 months were significantly
higher among pregnant women compared to women
who were not pregnant; households without children
compared to households with children; and adults
65 years and older compared to adults 64 years and
younger. After adjusting for gender, annual household
income, education, marital status, insurance status, race/
ethnicity and age, the prevalence of receiving influenza
vaccination within the past 12 months remained signifi-
cantly higher among adults who have current asthma
(PRR: 1.2, 95 % CI: 1.1 – 1.3), or have ever been diag-
nosed with diabetes (PRR: 1.2, 95 % CI: 1.2 – 1.3), high
blood pressure (PRR: 1.2, 95 % CI: 1.2 – 1.3), cancer
(excluding skin) (PRR: 1.1, 95 % CI: 1.1 – 1.2), and
COPD (PRR: 1.2, 95 % CI: 1.1 – 1.2) compared to those
who did not have these health conditions; and pregnant
women (PRR: 1.3, 95 % CI: 1.1 – 1.6) compared to women
who were not pregnant. After adjusting for gender, annual
household income, education, marital status, insurance
status, and race/ethnicity, the prevalence of receiving
influenza vaccination within the past 12 months remained
significantly higher among adults 65 years and older (PRR:
1.6, 95 % CI: 1.5 – 1.6) compared to adults 64 years and
younger.
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Discussion
The current article is unique in that its findings reflect
population-based data of influenza vaccination status
and its relation to specific health conditions and groups
prone to influenza-related complications in Kansas. In
2013, Kansas’ influenza vaccination prevalence was
42.2 % (95 % CI: 41.4 - 43.0), which is similar to the
national prevalence of 41.5 % (95 % CI: 41.4 - 41.9) [13].
Despite this similarity, current influenza vaccine cover-
age rates remain sub-optimal compared to the Healthy
People 2020 target objectives of 80 % vaccination rate
among pregnant women and non-institutionalized adults
18 to 64 years; and 90 % vaccination rate for non-
institutionalized high-risk adults 18 to 64 years, non-
institutionalized adults 65 years and older, and health
care personnel [7].
Results from this study show that influenza vaccin-
ation increased with age. This positive association is
consistent with national estimates [13]. Possible reasons
for lower vaccination rates among younger adults may
be lack of emphasis on vaccination in the younger popu-
lation from health care providers and historically low
seasonal influenza vaccination coverage in this popula-
tion [14]. In addition, lower vaccination rates among
adults between 18 and 49 years might suggest that youn-
ger adults do not feel the need to get vaccinated because
they are less prone to severe complications. However, a
recent study found that seasonal influenza vaccination
reduced the risk of flu-related hospitalization by 71.4 %
among adults of all ages [15]. Increasing flu vaccine
uptake among this group may not only reduce incident
influenza cases but also prevent transmission among
the population as a whole, ultimately reducing health
care costs. Furthermore, adults 65 years and older have
Medicare coverage and may likely have other medical
conditions driving their need to access the healthcare
system, which can increase their chance of getting the
influenza vaccine.
Table 1 Prevalence of influenza vaccine by socio-demographic
characteristics, 2013 KS BRFSS
Vaccinated Weighted % 95 % CI
Overall 42.2 41.4-43.0
Sex
Men 37.9 36.7-39.1
Women 46.3 45.2-47.3
Age Groups
18-24 years 26.5 23.8-29.1
25-34 years 32.9 30.8-35.1
35-44 years 34.8 32.8-36.9
45-54 years 38.8 36.9-40.6
55-64 years 48.6 47.0-50.2
65 + years 64.8 63.6-66.1
Race/ Ethnicity Groupsa
White Non-Hispanic 41.6 40.7-42.5
Black Non-Hispanic 37.6 33.3-41.9
Multiracial/Other Race Non-Hispanic 40.4 36.4-44.3
Hispanic 38.1 34.8-41.3
Marital Status
Married or member of an unmarried
couple
46.2 45.1-47.2
Divorced or separated 36.2 34.2-38.3
Widowed 61.5 59.3-63.6
Never married 28.0 26.0-30.0
Education Groups
Less Than High school 34.0 31.2-36.9
High school or GED 37.7 36.2-39.2
Some College 40.6 39.2-42.0
College Graduate 51.9 50.6-53.2
Annual Household Income Groups
Less than $15,000 31.7 28.9-34.4
$15,000-$24,999 36.6 34.6-38.7
$25,000-$34,999 40.1 37.7-42.6
$35,000-$49,999 43.0 40.8-45.2
$50,000 or more 47.6 46.3-48.9
Insurance Status
Uninsured 19.2 17.4-21.1
Insured 46.7 45.9-47.6
aPrevalence estimates for race and ethnicity were age-adjusted to the U.S.
2000 standard population
Table 2 Prevalence of influenza vaccination status by health risk
behaviors and chronic health conditions, Kansas BRFSS 2013
Percentage of adults Percentage of adults
vaccinated against not vaccinated
influenzaa against influenzaa
% 95 % CI % 95 % CI
Chronic Health Conditions
Asthma 47.4 44.6-50.2 41.7 40.9-42.5
Diabetes 57.5 55.2-59.9 40.5 39.7-41.4
High Blood Pressure 53.6 52.3-54.9 36.9 35.9-37.9
Cancer 57.8 55.1-60.5 41.0 40.2-41.8
COPD 51.0 48.0-54.0 41.6 40.8-42.4
Health Risk Groups
Pregnant Women 51.1 42.2-59.9 35.6 33.7-37.5
Household with children 36.6 35.1-38.1 45.4 44.5-46.3
People 65 years or older 64.8 63.6-66.1 36.8 35.8-37.7
People with BMI >40 41.9 38.1-45.6 42.4 41.6-43.3
American Indians 44.5 36.7-52.4 42.3 41.5-43.1
aChronic health condition and health risk group subcategories are not
mutually exclusive
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The lowest influenza vaccination prevalence was
found among adults without health care coverage
(19.2 %) compared to 46.7 % of those with health care
coverage (Table 1). In addition, results demonstrated
that influenza vaccination rates were lower among sub-
populations with lower educational attainment and
those with lower annual household incomes. These dis-
parities may reflect poorer access to medical care and/
or lower health literacy related to the importance of
preventive medical care [16]. It is important to increase
flu vaccination rates because immunization is the most
effective way to prevent influenza and its complications
[6]. Therefore, public health personnel should imple-
ment influenza vaccination programs or policies for
adults without health care coverage and those with low
socioeconomic status.
The prevalence rates of receiving influenza vaccination
within the past 12 months were statistically higher
among individuals with chronic health conditions prone
to influenza-related complications (current asthma, dia-
betes, high blood pressure, cancer excluding skin, and
COPD) compared to those who did not have these con-
ditions. Despite significantly higher seasonal influenza
vaccination rates among adults with chronic health
conditions, vaccination coverage was low compared to
Healthy People 2020 target objectives. Corresponding
adjusted prevalence rate ratios remained statistically sig-
nificant even after adjusting for healthcare coverage and
other social demographic factors. This suggests that
adults in Kansas with chronic health conditions had sta-
tistically higher rates of receiving the influenza vaccine
even after taking healthcare coverage and demographic
factors into consideration. Despite statistically significant
higher prevalence of seasonal influenza vaccination among
adults with chronic disease, the prevalence was only 1.1 to
1.2 times higher among those who have the conditions
compared to those who do not, after adjustment for social
demographic characteristics. This translates to a high
number of adults with chronic health conditions not actu-
ally getting vaccinated. One potential reason for this may
be that adults with chronic health conditions do not con-
sider their health conditions as putting them at high risk
for influenza related complications [14].
The prevalence rates of receiving influenza vaccination
within the past 12 months were significantly higher
among only two health risk groups prone to influenza-
related complications: pregnant women and adults
65 years and older. Similar to chronic health conditions,
this association likely reflects more routine use of health
care and thus more opportunities to receive the vaccin-
ation. The prevalence rate of receiving influenza vaccin-
ation within the past 12 months was significantly lower
among adults who lived in households with children.
One potential reason for the lower prevalence among
this group could be that adults are less concerned about
getting themselves vaccinated as long as the children
received the vaccination, since it has been demonstrated
that children contribute more to the spreading of influ-
enza in the population [17]. The prevalence rate of sea-
sonal influenza vaccination among pregnant women
and adults 65 years and older remained significantly
higher even after adjustment. This is especially import-
ant since the CDC estimated that more than 200,000
people in the United States are hospitalized each year
from flu-related illness, especially adults 65 years of age
and older [15].
Table 3 Crude and adjusted prevalence rate ratios (PRR) of influenza vaccination among health risk behaviors and chronic health
conditions, Kansas BRFSS 2013
Crude Adjusted
PRR 95 % CI P-Value PRR 95 % CI P-Value
Chronic Health Conditions
Asthma 1.1 1.1-1.2 <.01 1.2 1.1-1.3a <.01
Diabetes 1.4 1.4-1.5 <.01 1.2 1.2-1.3a <.01
High Blood Pressure 1.5 1.4-1.5 <.01 1.2 1.2-1.3a <.01
Cancer 1.4 1.4-1.9 <.01 1.1 1.1-1.2a <.01
COPD 1.2 1.2-1.3 <.01 1.2 1.1-1.2a <.01
Health Risk Groups
Pregnant Women 1.4 1.2-1.7 <.01 1.3 1.1-1.6a 0.03
Household with children 0.8 0.8-0.8 <.01 1.0 1.0-1.1a 0.25
People 65 years or older 1.8 1.7-1.8 <.01 1.6 1.5-1.6b <.01
People with BMI >40 1.0 0.9-1.1 0.77 1.1 1.0-1.2a 0.14
American Indians 1.1 0.9-1.3 0.57 1.2 1.0-1.4a 0.09
aModels adjusted for gender, annual household income, education, marital status, insurance status, race/ethnicity, & age
bModel adjusted for gender, annual household income, education, marital status, insurance status, & race/ethnicity
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These findings raise serious concerns about the low
levels of influenza vaccination coverage. These results
are important and useful in identifying and implement-
ing tailored programs to improve vaccination coverage
among adults prone to influenza-related complications.
In order to further improve vaccination coverage, pro-
viders should address barriers to delivery and acceptance
of influenza vaccination among adults with specified
health conditions and characteristics.
This study is not without limitations. First, data collected
via the BRFSS are cross-sectional; therefore, the demon-
strated associations do not infer causal relationships.
Second, these findings are based on self-reported data,
which may be prone to biases (reporting bias, misclassifica-
tion bias, etc.). Additional studies examining hospitaliza-
tions due to complications of the seasonal influenza,
primary care visits due to influenza, and beliefs and atti-
tudes towards immunization could help to further eluci-
date patterns of seasonal influenza vaccination in Kansas.
Conclusion
In conclusion, regardless of higher prevalence of influenza
vaccination among various subgroups, vaccination remains
sub-optimal among persons prone to influenza-related
complications. Results from this study can help inform
which subgroups may benefit from more intense health
education; however, there’s still a need to educate the popu-
lation as a whole. Some avenues to increase influenza vac-
cination coverage could include: greater public awareness of
the importance of influenza vaccination, especially for the
younger population; more public health campaign efforts to
target populations at increased risk of influenza-associated
complications; stronger recommendations for flu vaccin-
ation from professional organizations; increased emphasis
on the need for influenza vaccination by healthcare workers;
and automated reminder mechanisms for physicians.
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